Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Human Immunoglobulin (IM) is a plasma-derived biologic developed and manufactured by Zhejiang Haikang Biological Products. It consists of pooled IgG antibodies extracted from healthy human plasma, providing a broad spectrum of passive immunity. The product is specifically indicated for the prevention of measles and hepatitis A, as well as for providing passive immunity support in patients with immunodeficiency. Administered via intramuscular injection, it works by neutralizing specific pathogens and supplementing the recipient's antibody levels to prevent infection or manage immune deficiency states.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Human Immunoglobulin (IM) (Zhejiang Haikang Biological Products).